Neuropsychological and Psychosocial Foundations of Neuro-Oncology

— —

Herbert B. Newton, MD in Oncology-Neurosurgery (Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center) Ashlee R. Loughan (Associate Professor, Department of Neurology, Virginia Commonwealth University USA)

Neuropsychological and Psychosocial Foundations of Neuro-Oncology

Herbert B. Newton, MD in Oncology-Neurosurgery (Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center), Ashlee R. Loughan (Associate Professor, Department of Neurology, Virginia Commonwealth University USA)

$454.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
29 August 2024

Physiological & neuro-psychology, biopsychology; Cognition & cognitive psychology; Neurology & clinical neurophysiology; Neurosciences

Neuropsychological and Psychosocial Foundations of Neuro-Oncology provides an in-depth review of common cognitive, psychological, and social manifestations that occur in patients with brain cancer and other neuro-oncological issues. Chapters discuss primary CNS tumors, brain metastases, leptomeningeal disease, paraneoplastic disorders, and many other topics. Effects of CNS and systemic cancer treatment (i.e., radiotherapy, chemotherapy, immunotherapy) are also examined, as are current practices for rehabilitation and targets for essential future interventions in vulnerable populations.

This book is fully illustrated with pathology photomicrographs, CT and MRI images, tables, and molecular pathway diagrams. Bringing neuropsychological and behavioral health trial knowledge from the bench to the bedside, this volume is an essential reference for practicing neuro-oncologists, neuropsychologists, nurses, and others working in the field of neuro-oncology.

Edited by: Herbert B. Newton MD in Oncology-Neurosurgery (Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center), Ashlee R. Loughan (Associate Professor, Department of Neurology, Virginia Commonwealth University USA)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 276mm, Width: 216mm,
Weight: 1.980kg
ISBN: 9780443156632
ISBN 10: 0443156638
Pages: 626
Publication Date: 29 August 2024
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

SECTION I. Neuropsychological Foundations of Neuro-Oncology 1. History of neuro-oncology and neuropsychology 2. Neurocognitive functioning from a neuropsychological perspective 3. Taking a Therapeutic and Biopsychosocial Approach to the Neuropsychological Interview for Assessment of Brain Tumor Survivors 4. Cognitive Objective Testing and Procedures 5. Patient-Reported Assessment: Identifying Cognitive Concerns in Brain Tumor Patients 6. Quality of life and patient-reported outcomes in neuro-oncology clinical care and research SECTION II. Effects of Neuro-Oncology and Systemic Treatment on Cognitive Functioning 7. Imaging in Neuro-Oncology 8. Pathology and Treatment of Primary and Metastatic Brain Tumors 9. Overview of Systemic Treatment and Toxicity in Cancer Patients 10. Delirium and Mental Status Changes in Neuro-Oncology 11. The Neuropsychological Impact of Surgical Intervention and Utility of Awake Craniotomies 12. Neuropsychological Implications of Radiotherapy 13. Neuropsychologic manifestations of chemotherapy 14. Neuropsychological Issues Related to Immunotherapy 15. Neuropsychological Aspects of Blood or Bone Marrow Transplantation 16. Pediatric Brain Tumors: Neuropsychological Late Effects and Academic Implications SECTION III. Psychosocial Foundations of Neuro-Oncology 17. Depression in Neuro-Oncology 18. Anxiety in Neuro-Oncology 19. Personality and behavioral changes in Neuro-Oncology 20. Existential Distress in Neuro-Oncology 21. Body Image in Cancer 22. Fatigue/Sleep Issues in Neuro-Oncology 23. The Impact of Brain Tumor Location and Treatment on Sexual Function: Implications for clinical practice SECTION IV. Cognitive and Psychological Interventions 24. Evidence and clinical considerations for cognitive rehabilitation 25. Unpacking the Psycho-Pharmacologic and Psychological Burden of Neuro-Oncology 26. Psychotherapeutic Interventions in Neuro-Oncology 27. Alternative and Holistic Approaches to Neuro-Oncological Healthcare 28. Support Groups and Self-Help Resources 29. The Role of Social Work in Neuro-Oncology 30. Overview of Music Therapy and Art Therapy in Oncology 31. Spirituality in Neuro-oncology SECTION V. Supportive and Palliative Care in Neuro-Oncology 32. Symptom Management in Neuro-Oncology 33. Physical Rehabilitation in Neuro-Oncology 34. Advanced Care Planning in Neuro-Oncology 35. Psychiatric Issues in Terminal Care in Neuro-oncology 36. Palliative Care and Hospice Care in Neuro-Oncology 37. Ethical Issues in Neuro-Oncology Medical Care 38. Comprehensive Psychosocial Resources for Cancer Patients: The Gathering Place – An Evolving Model 39. Legal Issues in Cancer and Neuro-Oncology SECTION VI. Caregiving in Neuro-Oncology 40. The Experience of Caregivers of Patients in Neuro-Oncology 41. In-Home Care Resources in Neuro-Oncology

Herbert B. Newton, M.D., FAAN, is currently the Medical Director for the Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center, in Cleveland, Ohio, where he is also a Professor of Neurology and Solid Tumor Oncology, and holds the William Burton Risman Neurological Institute Chair in Memory and Cognition. Prior to that he was the Director of the Neuro-Oncology Center and Medical Neuro-Oncology Program at the Advent Health Cancer Institute and Advent Health Orlando Campus in Orlando, Florida. He is also retired as a Professor of Neurology and Neurosurgery, Dardinger Neuro-Oncology Center, Esther Dardinger Endowed Chair in Neuro-Oncology and Division of Neuro-Oncology at the Ohio State University Medical Center and James Cancer Hospital, in Columbus, Ohio. He is a Diplomate of the American Board of Psychiatry and Neurology, a Fellow of the American Academy of Neurology and Royal Society of Medicine, and a member of numerous national and international societies. Dr. Loughan is a licensed clinical neuropsychologist and Associate Professor in Neurology at Virginia Commonwealth University School of Medicine. She has developed a thriving neuropsychological and quality survival program at Massey Cancer Center, LiveNOW (Neuro-Oncology Wellness). Dr. Loughan is committed to a career in neuro-oncology and conducts practice-changing cancer prevention and control research aimed to improve patients cognitive and psychological outcomes. She has demonstrated a strong record of internal and external funding, focused on understanding and improving quality survival of those challenged by brain tumors. She has authored over 40 peer-reviewed manuscripts, 9 invited book chapters, and produced 100+ abstracts at local, national, and international academic conferences. Dr. Loughan was recently recognized as a VCU Emerging Scholar and serves on the American Brain Tumor Association Clinical Advisory Counsel. She is a clinician scientist invested in the field of neuro-oncology and psycho-oncology, especially the future of quality oncology care.